Skip to main content
ALCIDION GROUP LIMITED logo

ALCIDION GROUP LIMITED — Investor Relations & Filings

Ticker · ALC ISIN · AU000000ALC6 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 731 across all filing types
Latest filing 2019-06-25 Regulatory Filings
Country AU Australia
Listing ASX ALC

About ALCIDION GROUP LIMITED

https://www.alcidion.com

Alcidion Group Limited develops and delivers specialized software solutions designed to enhance patient safety and clinical productivity. The company’s core offering, Miya Precision, is an interoperable platform that consolidates data from disparate clinical systems to provide real-time insights, clinical decision support, and predictive analytics. Complementary products include Patientrack, which automates the monitoring of patient vitals and early warning scores, and Smartpage, a secure clinical communication and task management system. These integrated technologies facilitate digital transformation within hospital environments by streamlining workflows and reducing clinical risk. The company focuses on providing healthcare providers with actionable data to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
Western Sussex Hospitals Renew Patientrack Contract 2 pages 155.9KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the renewal of a product license contract between Alcidion Group Ltd and Western Sussex Hospitals NHS Trust. It details the contract duration, value, and background information about the product and the customer. There is no financial data, regulatory filing, or report content. It is not an annual or interim report, earnings release, or any other financial or regulatory filing. It is a corporate announcement about a contract renewal, which fits best under the category of a general regulatory announcement or miscellaneous filing that does not fit other categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-06-25 English
Alcidion Announces Non-Executive Director Appointment 2 pages 153.7KB
Board/Management Information Classification · 100% confidence The document is an announcement from Alcidion Group Ltd regarding the appointment of a new Non-Executive Director, Simon Chamberlain, and the stepping down of a current director, Geoffrey Rohrsheim. It focuses on changes in the company's board composition and provides background information on the new appointee. There is no financial data, report publication, or regulatory filing content. The document fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2019-06-24 English
Release of Securities from Escrow 1 page 153.1KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 17 June 2019 from Alcidion Group Limited regarding the release of securities from escrow in accordance with ASX Listing Rule 3.10A. It details the number of shares to be released, the background of these shares related to acquisitions, and the company's share trading policy. There is no financial data, no detailed report, and no mention of a report being attached or published. The content is focused on a capital structure event related to share release from escrow, which fits the category of Capital/Financing Update (CAP). The document length is 3296 characters, which is relatively short but contains substantive information about capital changes rather than just an announcement of a report publication or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2019-06-16 English
Response to ASX Price Query 4 pages 499.4KB
Regulatory Filings Classification · 100% confidence The document is a formal response letter from Alcidion Group Limited to the Australian Securities Exchange (ASX) regarding a price query about unusual trading activity in the company's securities. It addresses compliance with continuous disclosure obligations under ASX Listing Rules 3.1 and 3.1A, confirms no undisclosed material information exists, and discusses potential trading halts. The document is a regulatory communication related to market compliance and disclosure, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data but is a regulatory filing responding to a market query. Therefore, it fits best under the category of Regulatory Filings (RNS).
2019-05-29 English
Alcidion helps NSW Health build CDHR 1 page 147.0KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 20 May 2019 from Alcidion Group Ltd regarding a contract signed with NSW Health to build components of a Child Digital Health Record. It describes the contract value, project scope, and company background. There are no financial statements, regulatory forms, or detailed financial data. The length is only 2592 characters, which is quite short and typical of a press release or announcement. It does not fit categories like Annual Report, Interim Report, Earnings Release, or any detailed financial or governance report. It is an announcement of a contract signing, which is a capital/financing update or business update related to company operations. The best fitting category is Capital/Financing Update (CAP) as it relates to a contract engagement and project funding recognition in FY2020. Confidence is high given the clear nature of the announcement and absence of other report types.
2019-05-19 English
Alcidion Investor Presentation May 2019 16 pages 2.8MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and contains detailed information about the company's business model, market opportunity, competitive landscape, financial highlights for Q3 FY2019, growth strategy, capital structure, major shareholders, and board members. It is structured as a presentation aimed at investors, focusing on financials, strategy, and market position. There are no full financial statements or comprehensive annual or quarterly report data, nor is it an announcement of a report publication or regulatory filing. The length (over 14,000 characters) and content confirm it is a detailed presentation rather than a brief announcement or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2019-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.